Technical Analysis for LIVN - LivaNova PLC
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 62.05 | -0.92% | -0.57 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | -0.92% | |
Expansion Breakout | Bullish Swing Setup | -0.92% | |
Pocket Pivot | Bullish Swing Setup | -0.92% | |
Volume Surge | Other | -0.92% | |
Wide Range Bar | Range Expansion | -0.92% | |
New 52 Week High | Strength | -0.92% | |
Earnings Movers | Other | -0.92% | |
Multiple of Ten Bullish | Other | -0.92% | |
Above Upper BB | Strength | -0.92% | |
Gapped Up | Strength | -0.92% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 2 hours ago |
Down 3% | about 3 hours ago |
Down 1 ATR | about 3 hours ago |
Down 2 % | about 4 hours ago |
Fell Below Upper Bollinger Band | about 4 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/01/2024
LivaNova PLC Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Medical Equipment Healthcare Providers Heart Failure Cardiology Depression Prosthetics Obstructive Sleep Apnea Repair Products Cardiac Surgery Cardiopulmonary Bypass Therapeutic Solutions
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 63.21 |
52 Week Low | 42.82 |
Average Volume | 787,769 |
200-Day Moving Average | 52.06 |
50-Day Moving Average | 54.45 |
20-Day Moving Average | 54.68 |
10-Day Moving Average | 55.52 |
Average True Range | 1.98 |
RSI (14) | 73.68 |
ADX | 15.58 |
+DI | 42.46 |
-DI | 12.89 |
Chandelier Exit (Long, 3 ATRs) | 57.28 |
Chandelier Exit (Short, 3 ATRs) | 57.64 |
Upper Bollinger Bands | 59.11 |
Lower Bollinger Band | 50.26 |
Percent B (%b) | 1.4 |
BandWidth | 16.20 |
MACD Line | 1.07 |
MACD Signal Line | 0.42 |
MACD Histogram | 0.6539 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 69.51 | ||||
Resistance 3 (R3) | 68.94 | 66.07 | 68.36 | ||
Resistance 2 (R2) | 66.07 | 64.32 | 66.36 | 67.97 | |
Resistance 1 (R1) | 64.35 | 63.24 | 65.21 | 64.92 | 67.59 |
Pivot Point | 61.48 | 61.48 | 61.92 | 61.77 | 61.48 |
Support 1 (S1) | 59.76 | 59.73 | 60.62 | 60.33 | 57.65 |
Support 2 (S2) | 56.89 | 58.65 | 57.18 | 57.27 | |
Support 3 (S3) | 55.17 | 56.89 | 56.88 | ||
Support 4 (S4) | 55.74 |